E2F in vivo binding specificity: Comparison of consensus versus nonconsensus binding sites

被引:111
作者
Rabinovich, Alina [1 ,2 ]
Jin, Victor X. [3 ,4 ]
Rabinovich, Roman [1 ,2 ]
Xu, Xiaoqin [1 ,2 ]
Farnham, Peggy J. [1 ,2 ]
机构
[1] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA
[2] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA
[3] Univ Memphis, Bioinformat Program, Memphis, TN 38152 USA
[4] Univ Memphis, Dept Biol, Memphis, TN 38152 USA
关键词
D O I
10.1101/gr.080622.108
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have previously shown that most sites bound by E2F family members in vivo do not contain E2F consensus motifs. However, differences between in vivo target sites that contain or lack a consensus E2F motif have not been explored. To understand how E2F binding specificity is achieved in vivo, we have addressed how E2F family members are recruited to core promoter regions that lack a consensus motif and are excluded from other regions that contain a consensus motif. Using chromatin immunoprecipitation coupled with DNA microarray analysis (ChIP-chip) assays, we have shown that the predominant factors specifying whether E2F is recruited to an in vivo binding site are ( 1) the site must be in a core promoter and (2) the region must be utilized as a promoter in that cell type. We have tested three models for recruitment of E2F to core promoters lacking a consensus site, including ( 1) indirect recruitment, (2) looping to the core promoter mediated by an E2F bound to a distal motif, and ( 3) assisted binding of E2F to a site that weakly resembles an E2F motif. To test these models, we developed a new in vivo assay, termed eChIP, which allows analysis of transcription factor binding to isolated fragments. Our findings suggest that in vivo ( 1) a consensus motif is not sufficient to recruit E2Fs, (2) E2Fs can bind to isolated regions that lack a consensus motif, and (3) binding can require regions other than the best match to the E2F motif.
引用
收藏
页码:1763 / 1777
页数:15
相关论文
共 57 条
[1]   Analysis of the mechanisms mediating tumor-specific changes in gene expression in human liver tumors [J].
Acevedo, Luis G. ;
Bieda, Mark ;
Green, Roland ;
Farnham, Peggy J. .
CANCER RESEARCH, 2008, 68 (08) :2641-2651
[2]   Genome-scale ChIP-chip analysis using 10,000 human cells [J].
Acevedo, Luis G. ;
Iniguez, A. Leonardo ;
Holster, Heather L. ;
Zhang, Xinmin ;
Green, Roland ;
Farnham, Peggy J. .
BIOTECHNIQUES, 2007, 43 (06) :791-797
[3]   FUNCTIONAL SYNERGY BETWEEN DP-1 AND E2F-1 IN THE CELL CYCLE-REGULATING TRANSCRIPTION FACTOR DRTF1/E2F [J].
BANDARA, LR ;
BUCK, VM ;
ZAMANIAN, M ;
JOHNSTON, LH ;
LATHANGUE, NB .
EMBO JOURNAL, 1993, 12 (11) :4317-4324
[4]   High-resolution profiling of histone methylations in the human genome [J].
Barski, Artern ;
Cuddapah, Suresh ;
Cui, Kairong ;
Roh, Tae-Young ;
Schones, Dustin E. ;
Wang, Zhibin ;
Wei, Gang ;
Chepelev, Iouri ;
Zhao, Keji .
CELL, 2007, 129 (04) :823-837
[5]   The mammalian epigenome [J].
Bernstein, Bradley E. ;
Meissner, Alexander ;
Lander, Eric S. .
CELL, 2007, 128 (04) :669-681
[6]   Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome [J].
Bieda, M ;
Xu, XQ ;
Singer, MA ;
Green, R ;
Farnham, PJ .
GENOME RESEARCH, 2006, 16 (05) :595-605
[7]   Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1 [J].
Carroll, JS ;
Liu, XS ;
Brodsky, AS ;
Li, W ;
Meyer, CA ;
Szary, AJ ;
Eeckhoute, J ;
Shao, WL ;
Hestermann, EV ;
Geistlinger, TR ;
Fox, EA ;
Silver, PA ;
Brown, M .
CELL, 2005, 122 (01) :33-43
[8]   Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs [J].
Cawley, S ;
Bekiranov, S ;
Ng, HH ;
Kapranov, P ;
Sekinger, EA ;
Kampa, D ;
Piccolboni, A ;
Sementchenko, V ;
Cheng, J ;
Williams, AJ ;
Wheeler, R ;
Wong, B ;
Drenkow, J ;
Yamanaka, M ;
Patel, S ;
Brubaker, S ;
Tammana, H ;
Helt, G ;
Struhl, K ;
Gingeras, TR .
CELL, 2004, 116 (04) :499-509
[9]   Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription [J].
Christensen, J ;
Cloos, P ;
Toftegaard, U ;
Klinkenberg, D ;
Bracken, AP ;
Trinh, E ;
Heeran, M ;
Di Stefano, L ;
Helin, K .
NUCLEIC ACIDS RESEARCH, 2005, 33 (17) :5458-5470
[10]   Gene therapy progress and prospects: Episomally maintained self-replicating systems [J].
Conese, M ;
Auriche, C ;
Ascenzioni, F .
GENE THERAPY, 2004, 11 (24) :1735-1741